CN101095779A - Chinese patent drug for treating diabetes erysipelas - Google Patents
Chinese patent drug for treating diabetes erysipelas Download PDFInfo
- Publication number
- CN101095779A CN101095779A CNA2007101184125A CN200710118412A CN101095779A CN 101095779 A CN101095779 A CN 101095779A CN A2007101184125 A CNA2007101184125 A CN A2007101184125A CN 200710118412 A CN200710118412 A CN 200710118412A CN 101095779 A CN101095779 A CN 101095779A
- Authority
- CN
- China
- Prior art keywords
- parts
- erysipelas
- diabetic
- chinese patent
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 22
- 201000000297 Erysipelas Diseases 0.000 title claims abstract description 21
- 229940079593 drug Drugs 0.000 title description 15
- 241000628997 Flos Species 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000555712 Forsythia Species 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 20
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 206010007247 Carbuncle Diseases 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 208000015220 Febrile disease Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 206010017533 Fungal infection Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000001380 Diabetic Ketoacidosis Diseases 0.000 description 1
- 206010053695 Diabetic dermopathy Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating diabetic erysipelas, which is prepared from more than ten kinds of Chinese medicinal herbs including capsule of weeping forsythia, gentian root, bupleurum root and plantain seed. The medicament has the advantages of assured curative effect, safe and convenient application, no toxic and side effects, and low price.
Description
Technical field
The present invention relates to a kind of Chinese patent medicine for the treatment of diabetic erysipelas, is that a kind of diabetic erysipelas for the treatment of is the Chinese medicine preparation of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
The non-specific dermatosis of diabetes is meant that diabetics is subjected to antibacterial or fungal infection and the dermatosis that causes accounts for about 20% of diabetic dermopathy, and the state of an illness is generally heavier.Infection can make the diabetes state of an illness increase the weight of, and blood sugar increasing is so that bring out diabetic ketoacidosis.And not good progress and the deterioration that impels infection of the state of an illness of diabetes control, even cause septicemia, make the state of an illness be difficult to control.The common infectious skin pathological changes of diabetes is divided into bacterial infection and fungal infection two big classes.The diabetes erysipelas is commonly called as " erysipelas ", characteristics be diseased region occur large stretch of red, swollen, hot, bitterly, with a kind of infectious skin pathological changes of General Symptomies such as headache, fever.Primary disease is sent out in spring and autumn well, and be 2～5 days incubation period.Contain and demonstrate,prove clinically, pyretic toxicity is joined the army disease type Coryza Treated by Syndrome Differentiation such as card, obtains very good effect by the vehement fire syndrome of branch wind heat, Liver Channel stagnated fire card, damp and hot fire for the traditional Chinese medical science.Invent a kind of not only safety but also effective Chinese medicine preparation, be significant.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of diabetic erysipelas.Have determined curative effect, safe ready, have no side effect, cheap characteristics.
The present invention is made by the following weight proportion raw material:
1.0～4 parts of 1.5～6 parts of Fructus Gardeniae of 1.5～6 parts of Fructus Forsythiaes of Flos Lonicerae
1.0～4 parts of 1.0～4 parts of Flos Chrysanthemi Indicis of 1.0～4 parts of Radix Bupleuri of Herba Violae
0.1～2 part of 1.0～4 parts of Cortex Moutan of 1.0～4 portions of Rhizoma Alismatis of Herba Taraxaci
0.1～2 part of 0.1～2 portion of Semen Plantaginis of 0.1～2 portion of Cortex Phellodendri of Radix Gentianae.
The weight proportion of each raw material of optimization formula of the present invention is:
1.5～2.5 parts of 2.5～3.5 parts of Fructus Gardeniae of 2.5～3.5 parts of Fructus Forsythiaes of Flos Lonicerae
1.5～2.5 parts of 1.5～2.5 parts of Flos Chrysanthemi Indicis of 1.5～2.5 parts of Radix Bupleuri of Herba Violae
0.5～1.5 part of 1.5～2.5 parts of Cortex Moutan of 1.5～2.5 portions of Rhizoma Alismatis of Herba Taraxaci
0.5～1.5 part of 0.5～1.5 portion of Semen Plantaginis of 0.5～1.5 portion of Cortex Phellodendri of Radix Gentianae.
The weight proportion of each raw material of optimum formula of the present invention is:
2 parts of 3 parts of Fructus Gardeniae of 3 parts of Fructus Forsythiaes of Flos Lonicerae
2 parts of 2 parts of Flos Chrysanthemi Indicis of 2 parts of Radix Bupleuri of Herba Violae
1 part of 2 parts of Cortex Moutan of 2 portions of Rhizoma Alismatis of Herba Taraxaci
1 part of 1 portion of Semen Plantaginis of 1 portion of Cortex Phellodendri of Radix Gentianae.
Drug action mechanism among the present invention is as follows:
The Flos Lonicerae property of medicine is sweet, and is cold.Attach to the lung and stomach meridians.Effect with heat-clearing and toxic substances removing.Can treat the heating of affection due to external wind and heat or epidemic febrile disease, heatstroke, toxic-heat and blood stasis, carbuncle furuncle, sore throat, multiple infectious disease etc.(the 1972nd page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Fructus Forsythiae property of medicine hardship is slightly cold.Return lung, the heart, gallbladder meridian.Has heat-clearing and toxic substances removing, the effect of dispersing swelling and dissipating binds.Can treat anemopyretic cold, epidemic febrile disease, pyretic stranguria urine retention, carbuncle, toxic swelling, scrofula, goiter, sore throat etc.(the 1554th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Fructus Gardeniae property of medicine hardship, cold.GUIXIN, liver, lung, stomach, tri-jiao channel.Has the pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, the effect of removing pathogenic heat from blood and toxic substance from the body.It is vexed to treat calentura, the liver-fire conjunctival congestion, and headache, jaundice due to damp-heat, stranguria is spitted blood, epistaxis, dysentery, hematuria, aphtha of the mouth and tongue, sore swollen toxin is sprained and is swollen and ache etc.(the 2242nd page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Herba Violae property of medicine hardship, suffering, cold.GUIXIN, Liver Channel.Has heat-clearing and toxic substances removing, the effect of dampness removing heat from blood.Can treat furuncle carbuncle, erysipelas, mumps, acute mastitis, acute appendicitis, scrofula, damp-heat dysentery, jaundice, conjunctival congestion and swelling pain, venom etc.(the 3306th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Radix Bupleuri nature and flavor hardship, be slightly cold.Return liver, gallbladder meridian.Effect with reconciling superficies and interior, soothing the liver, yang invigorating.Can treat alternate attack of chill and fever, fullness in the chest and hypochondriac pain, deafness, headache and dizziness, malaria, dysentery proctoptosis, menoxenia, uterine prolapse, flu, upper respiratory tract infection, hepatitis, cholecystitis etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1004th page).
Flos Chrysanthemi Indici nature and flavor hardship, suffering, cold.Return lung, Liver Channel.Has heat-clearing and toxic substances removing, the effect of dispelling wind suppressing the hyperactive liver.Cure mainly furuncle, carbuncle, erysipelas, eczema, dermatitis, anemopyretic cold, laryngopharynx swelling and pain, headache, dizzy etc.(the 2968th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Herba Taraxaci property of medicine hardship, sweet, cold.Return liver, stomach warp.Has heat-clearing and toxic substances removing, the effect of eliminating carbuncle eliminating stagnation.Can treat acute mastitis, lung abscess, acute appendicitis, mumps, scrofula, furuncle carbuncle toxin, conjunctival congestion and swelling pain, cat fever, cough, laryngopharynx swelling and pain, gastritis, enteritis, dysentery, hepatitis, cholecystitis, urinary tract infection, snake bite and insect sting, burn and scald etc.(the 3427th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The Rhizoma Alismatis property of medicine is sweet, light, and is cold.Return kidney, urinary bladder channel.Have promoting diuresis to eliminate damp pathogen, treating stranguria effect expels the heat-evil.Can treat dysuria, the puckery pain of pyretic stranguria, the edema distension is had loose bowels, dizziness due to fluid-retention, seminal emission etc.(the 2067th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Cortex Moutan property of medicine hardship, suffering are slightly cold.GUIXIN, liver, kidney channel.Has clearing away heat and cooling blood, the effect of promoting blood circulation to remove blood stasis.Can treat the epidemic febrile disease pathogenic heat attacking blood system in febrile diseases, send out speckle, tell nosebleed, the calentura later stage, hot Fu Yin divided heating, osteopyrexia and fever, and amenorrhea due to stagnation of blood, dysmenorrhea, mass in the abdomen, carbuncle sore tumefacting virus falls and pounces on the pain of injury, rheumatic arthralgia etc.(the 1578th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
Radix Gentianae nature and flavor hardship, cold.Return liver, gallbladder meridian.Have eliminating pathogen in the liver gallbladder fire, the clear part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels is wet, relieving convulsion making eye bright, and the malaria protozoon is good for the stomach, the effect that protects the liver.Can treat that Liver Channel intenseness of heat, infantile convulsion are manic, encephalitis B, headache, conjunctival congestion, pharyngalgia, jaundice, hematodiarrhoea, the swollen skin infection of pain, scrotum swell and ache, pudendum pruritus due to damp pathogen, hypertension dizziness tinnitus, chest and hypochondrium, acute infectious hepatitis, cystitis, skin infection swell and ache etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 413rd page).
Cortex Phellodendri property of medicine hardship, cold.Return kidney, bladder, large intestine channel.Has heat clearing and damp drying, the effect of eliminating fire and detoxication.Can treat hygropyretic dysentery, have loose bowels, jaundice, nocturnal emission, stranguria with turbid discharge, leukorrhagia, hectic fever due to YIN-deficiency consumptive fever ， Wei Bi, and aphtha of the mouth and tongue, conjunctival congestion and swelling pain, skin sore, skin eczema etc.(the 2823rd page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The Semen Plantaginis property of medicine is sweet, light, is slightly cold.Return lung, liver, kidney, urinary bladder channel.Have heat clearing away, diuresis makes eye bright, the expectorant effect.Can treat urinary obstruction, stranguria with turbid discharge, leukorrhagia, edema, the heat-damp in summer dysentery, conjunctival congestion is hidden from view, and the expectorant heat syndrome cough is breathed heavily etc.(the 539th page of Shanghai science tech publishing house second edition write by " Chinese medicine voluminous dictionary " Nanjing University of Traditional Chinese Medicine).
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch drug with Radix Gentianae, Flos Lonicerae and Fructus Forsythiae; With Fructus Gardeniae, Radix Bupleuri, Flos Chrysanthemi Indici, Herba Violae, Herba Taraxaci and Rhizoma Alismatis is ministerial drug; With Cortex Moutan, Semen Plantaginis and Cortex Phellodendri is adjuvant.All medicines are harmonious, and are total to the tool clearing away heat-damp and promoting diuresis, the effect of removing pathogenic heat from blood and toxic substance from the body.The treatment diabetic erysipelas has determined curative effect, has no side effect taking convenience, cheap characteristics.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of Pharmacopoeia of People's Republic of China, utilizes the comprehensive function treatment diabetic erysipelas of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Show that through the acute and chronic toxicity test of animal the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, rich in proteins in the medicine of the present invention, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid also contains various trace elements such as Saponin, plant sterol and calcium, is beneficial to absorption of human body, health invigorating.
3, the present invention not only can effectively treat diabetic erysipelas, and the prevention of diabetic erysipelas is also had good effect, and the treatment diabetic erysipelas has determined curative effect, has no side effect taking convenience, cheap characteristics.
For showing the therapeutic effect of medicine of the present invention, as follows through clinical test results to the treatment diabetic erysipelas; Treatment diabetic erysipelas patient 22 examples.Take the embodiment decoction, each 1 bag, two to three times on the one, take half an hour ante cibum.Seven days is a course of treatment, take continuously three the course of treatment observe the curative effect.10 examples of fully recovering account for 45.45%, and 9 examples that take a turn for the better account for 40.91%, and invalid 3 examples account for 13.64%, and total effective rate reaches 86.36%.After three course of therapy, patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
The embodiment decoction takes by weighing raw material by following weight:
2 parts of 3 parts of Fructus Gardeniae of 3 parts of Fructus Forsythiaes of Flos Lonicerae
2 parts of 2 parts of Flos Chrysanthemi Indicis of 2 parts of Radix Bupleuri of Herba Violae
1 part of 2 parts of Cortex Moutan of 2 portions of Rhizoma Alismatis of Herba Taraxaci
1 part of 1 portion of Semen Plantaginis of 1 portion of Cortex Phellodendri of Radix Gentianae.
Preparation method is to get above-mentioned raw materials to clean roguing, dries, and is ground into granule, soaks 1 hour, puts and decocts with water secondary in the multi-function extractor, adds up the water of 10 times of amounts of medical material for the first time, decocts 1.5～2 hours, gets decocting liquid, filters.Add up for the second time the water of 7 times of amounts of medical material, decocted 1～1.2 hour, get decocting liquid twice, filter, in the heat-sealing bag, 105 ℃ of high temperature sterilizes, packing is promptly.The decoction of the treatment diabetic erysipelas that the present invention makes is that plastic packaging is packed, and every bag of 210ml is oral, one time one bag, every day two to three times.Seven days is a course of treatment.
Claims (3)
1, a kind of Chinese patent medicine for the treatment of diabetic erysipelas is characterized in that it is made by the following weight proportion raw material:
1.0～4 parts of 1.5～6 parts of Fructus Gardeniae of 1.5～6 parts of Fructus Forsythiaes of Flos Lonicerae
1.0～4 parts of 1.0～4 parts of Flos Chrysanthemi Indicis of 1.0～4 parts of Radix Bupleuri of Herba Violae
0.1～2 part of 1.0～4 parts of Cortex Moutan of 1.0～4 portions of Rhizoma Alismatis of Herba Taraxaci
0.1～2 part of 0.1～2 portion of Semen Plantaginis of 0.1～2 portion of Cortex Phellodendri of Radix Gentianae.
2, a kind of Chinese patent medicine for the treatment of diabetic erysipelas according to claim 1, wherein the weight proportion of each raw material is:
1.5～2.5 parts of 2.5～3.5 parts of Fructus Gardeniae of 2.5～3.5 parts of Fructus Forsythiaes of Flos Lonicerae
1.5～2.5 parts of 1.5～2.5 parts of Flos Chrysanthemi Indicis of 1.5～2.5 parts of Radix Bupleuri of Herba Violae
0.5～1.5 part of 1.5～2.5 parts of Cortex Moutan of 1.5～2.5 portions of Rhizoma Alismatis of Herba Taraxaci
0.5～1.5 part of 0.5～1.5 portion of Semen Plantaginis of 0.5～1.5 portion of Cortex Phellodendri of Radix Gentianae.
3, a kind of Chinese patent medicine for the treatment of diabetic erysipelas according to claim 1, wherein the weight proportion of each raw material is:
2 parts of 3 parts of Fructus Gardeniae of 3 parts of Fructus Forsythiaes of Flos Lonicerae
2 parts of 2 parts of Flos Chrysanthemi Indicis of 2 parts of Radix Bupleuri of Herba Violae
1 part of 2 parts of Cortex Moutan of 2 portions of Rhizoma Alismatis of Herba Taraxaci
1 part of 1 portion of Semen Plantaginis of 1 portion of Cortex Phellodendri of Radix Gentianae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101184125A CN101095779A (en) | 2007-07-05 | 2007-07-05 | Chinese patent drug for treating diabetes erysipelas |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101184125A CN101095779A (en) | 2007-07-05 | 2007-07-05 | Chinese patent drug for treating diabetes erysipelas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101095779A true CN101095779A (en) | 2008-01-02 |
Family
ID=39010000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101184125A Pending CN101095779A (en) | 2007-07-05 | 2007-07-05 | Chinese patent drug for treating diabetes erysipelas |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101095779A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626454A (en) * | 2012-05-10 | 2012-08-08 | 蔡立 | Traditional Chinese medicine combination for treating erysipelas |
| CN105362823A (en) * | 2015-12-24 | 2016-03-02 | 青岛华之草医药科技有限公司 | Traditional Chinese medicine preparation for treating erysipelas |
| CN105412704A (en) * | 2015-12-24 | 2016-03-23 | 青岛华之草医药科技有限公司 | Method for preparing Chinese herbal preparation for treating erysipelas |
-
2007
- 2007-07-05 CN CNA2007101184125A patent/CN101095779A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102626454A (en) * | 2012-05-10 | 2012-08-08 | 蔡立 | Traditional Chinese medicine combination for treating erysipelas |
| CN105362823A (en) * | 2015-12-24 | 2016-03-02 | 青岛华之草医药科技有限公司 | Traditional Chinese medicine preparation for treating erysipelas |
| CN105412704A (en) * | 2015-12-24 | 2016-03-23 | 青岛华之草医药科技有限公司 | Method for preparing Chinese herbal preparation for treating erysipelas |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101085264A (en) | Traditional Chinese medicine preparation for treating urinary tract infection | |
| CN101116715A (en) | Chinese patent drug for treating non-gonococcal urethritis | |
| CN101066356A (en) | Chinese medicine for treating sterility of epididymitis | |
| CN101095779A (en) | Chinese patent drug for treating diabetes erysipelas | |
| CN101129494A (en) | Traditional Chinese medicine composition for treating post partum hypogalactia | |
| CN101129627A (en) | Traditional Chinese medicine formulated product for treating post partum toxin fever | |
| CN101095915A (en) | Chinese traditional medicine for treating diabetes cholecystitis | |
| CN101125191A (en) | Traditional Chinese medicine composition for curing non-gonococcal urethritis | |
| CN101095816A (en) | Chinese traditional medicine preparations for treating diabetic neurogenic bladder | |
| CN101116701A (en) | Chinese traditional medicine composition for treating trichomonal vaginitis | |
| CN101116735A (en) | Chinese traditional medicine preparations for treating trichomonal vaginitis | |
| CN101085207A (en) | Traditional Chinese medicine preparation for treating hyperthyroidism | |
| CN101085256A (en) | Traditional Chinese medicine for treating lupoid nephritis | |
| CN101095776A (en) | Chinese patent drug for treating diabetes deafness | |
| CN101085259A (en) | Traditional Chinese medicine decoction for treating chronic nephritis | |
| CN101095772A (en) | Chinese traditional medicine preparations for treating diabetic furuncle | |
| CN101085254A (en) | Traditional Chinese medicine for treating uric acid nephritis | |
| CN101129724A (en) | Traditional Chinese medicine formulated product for treating salpingitis | |
| CN101095806A (en) | Chinese medicine preparation for treating diabetes skin pruritus | |
| CN101095831A (en) | Chinese traditional medicine preparations for treating diabetes folliculitis | |
| CN101129990A (en) | Traditional Chinese medicine preparation for treating colpitis mycotica | |
| CN101085312A (en) | Traditional Chinese medicine for treating hyperdyroidism | |
| CN101066321A (en) | Chinese medicine prepn for treating sterility of oligospermia | |
| CN101085311A (en) | Traditional Chinese medicine composition for treating moody state during menstruation | |
| CN101129719A (en) | Traditional Chinese medicine composition for treating bacteroidal colpitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080102 |